Medications used to treat Parkinson’s disease include monoamine oxidase-B inhibitors (selegiline), presynaptic releasing agents (amantadine, anticholinergic agents), and catechol-O-methyltransferase (COMT) inhibitors (hyoscyamine, benztropine), all of which may potentially affect sleep (Chrisp et al., 1991).

Authors

• Person: Colten HR, Altevogt BM Organization: National Academies Press
  Extent and Health Consequences of Chronic Sleep Loss and ... - NCBI

Sources

• Extent and Health Consequences of Chronic Sleep Loss and ... - NCBI www.ncbi.nlm.nih.gov Colten HR, Altevogt BM · National Academies Press via serper

Referenced by nodes (2)

• sleep concept
• Parkinson's disease concept